Blog

GlaxoSmithKline's chief executive Sir Andrew Witty was granted an exclusive audience with the health secretary and other Whitehall officials to air his ...

Lundbeck Canada announced today that Health Canada has approved Trintellix (vortioxetine hydrobromide) for the treatment of major depressive disorder (MDD), a ...

10 January 2014 - Plans for NICE to take into account the benefit to wider society of new drugs licensed for ...

District Health Boards are poised to save more than $100 million over five years as a result of PHARMAC’s expanded ...

Lama Al-Akhras was bracing for life in a wheelchair last week as her body struggled with a rare and fatal disease. ...

Thank you to all those who responded to the hospital medical devices discussion document released in May 2014 either in ...

Health Minister Sussan Ley has confirmed the government will tackle "perverse incentives" in the health system by removing over-the-counter medications ...

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second product under a new accelerated review process ...

A drug that prevents elderly people losing their sight should be routinely available on the NHS, says the Royal College ...

EFPIA, the European Federation of Pharmaceutical Industries and Associations, today criticised the intent of the French government to broadly enlarge ...

Medicines Australia welcomes the Australian Government’s recognition of the importance of the PBS in the 2014-15 Federal Budget. ...

[:content [\1 \9 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \T \e \n \space \n \e \w \space \m \e \d \i \c \i \n \e \s \space \t \o \space \t \r \e \a \t \space \a \space \r \a \n \g \e \space \o \f \space \i \l \l \n \e \s \s \e \s \space \f \r \o \m \space \r \a \r \e \space \f \o \r \m \s \space \o \f \space \c \a \n \c \e \r \space \t \o \space \s \k \i \n \space \c \o \n \d \i \t \i \o \n \s " ..."]]

Stephen Whitehead, ABPI CEO, comments on NHS England's decision to delist 16 cancer medicines. ...

Australian patients have missed out on 75 per cent of the breakthrough new medicines released in the last five years, new ...